Antibody-Drug Conjugates for Breast Cancer: How They Work and What to Expect

What are antibody-drug conjugates (ADCs), and how do they revolutionize breast cancer treatment? Join Dr. Jennifer Griggs as she explains how ADCs, such as T-DM1 (Kadcyla) and T-DXd (Enhertu), work to deliver targeted therapy directly to tumor cells. Learn about their effectiveness, potential side effects, and how these innovative treatments are improving outcomes for breast cancer patients. Get your personalized Yerbba Report at: https://www.yerbba.com/ Connect With Yerbba! INSTAGRAM:   / yerbba   FACEBOOK:   / yerbba.breast.cancer   BLOG: https://www.yerbba.com/blog #breastcancer #breastcancertreatment #cancertreatment #cancersupport Disclaimer: Yerbba YouTube videos are for informational purposes only, do not constitute medical advice, and are not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your medical team, mental health professional, or other qualified health provider with any questions you may have regarding your medical condition.